ATP6V(0)d2 controls Leishmania parasitophorous vacuole biogenesis via cholesterol homeostasis

Imagem de Miniatura
Arquivos
art_PESSOA_ATP6V0d2_controls_Leishmania_parasitophorous_vacuole_biogenesis_via_cholesterol_2019.PDF (4.67 MB)
Citações na Scopus
18
Tipo de produção
article
Data de publicação
2019
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
PUBLIC LIBRARY SCIENCE
Autores
PESSOA, Carina Carraro
ORIKAZA, Cristina Mary
CORTEZ, Cristian
LEVATTI, Erica Valadares de Castro
BADARO, Ana Carolina Benites
YAMAMOTO, Joyce Umbelino da Silva
D'ALMEIDA, Vania
Citação
PLOS PATHOGENS, v.15, n.6, article ID e1007834, 32p, 2019
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
V-ATPases are part of the membrane components of pathogen-containing vacuoles, although their function in intracellular infection remains elusive. In addition to organelle acidification, V-ATPases are alternatively implicated in membrane fusion and anti-inflammatory functions controlled by ATP6V(0)d2, the d subunit variant of the V-ATPase complex. Therefore, we evaluated the role of ATP6V(0)d2 in the biogenesis of pathogen-containing vacuoles using ATP6V(0)d2 knock-down macrophages infected with the protozoan parasite Leishmania amazonensis. These parasites survive within IFN gamma/LPS-activated inflammatory macrophages, multiplying in large/fusogenic parasitophorous vacuoles (PVs) and inducing ATP6V(0)d2 upregulation. ATP6V(0)d2 knock-down decreased macrophage cholesterol levels and inhibited PV enlargement without interfering with parasite multiplication. However, parasites required ATP6V(0)d2 to resist the influx of oxidized low-density lipoprotein (ox-LDL)-derived cholesterol, which restored PV enlargement in ATP6V(0)d2 knock-down macrophages by replenishing macrophage cholesterol pools. Thus, we reveal parasite-mediated subversion of host V-ATPase function toward cholesterol retention, which is required for establishing an inflammation-resistant intracellular parasite niche. Author summary V-ATPases control acidification and other processes at intracellular vesicles that bacteria and parasites exploit as compartments for replication and immune evasion. We report that the protozoan intracellular parasite Leishmania amazonensis resists inflammatory macrophage immune responses and upregulates an alternative isoform of subunit d of V-ATPase (ATP6V(0)d2). Leishmania are still sequestered within acidified parasitophorous vacuoles (PVs) in cells lacking ATP6V(0)d2, but these PVs do not enlarge in volume, a distinguishing feature of intracellular infection by these parasites. Cholesterol levels in ATP6V(0)d2-deficient cells are reduced and exogenous cholesterol repletion can restore vacuole size, leading to enhanced parasite killing. This study demonstrates the ATP6V(0)d2-mediated interplay of macrophage cholesterol retention and control of the biogenesis of large pathogen-containing vacuoles. The study provides grounds for the development of new therapeutic strategies for diseases caused by intracellular pathogens sheltered in host cell compartments.
Palavras-chave
URI
https://observatorio.fm.usp.br/handle/OPI/33549
Referências
  1. Aflaki E, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008659
  2. Alexander J, 1999, J CELL SCI, V112, P2993
  3. Andrade-Neto VV, 2011, ACTA TROP, V119, P194, DOI 10.1016/j.actatropica.2011.05.001
  4. ARANDA CMA, 1992, P NATL ACAD SCI USA, V89, P10079, DOI 10.1073/pnas.89.21.10079
  5. Attie AD, 2005, CELL METAB, V1, P290, DOI 10.1016/j.cmet.2005.04.006
  6. BARRAL A, 1995, INT J DERMATOL, V34, P474, DOI 10.1111/j.1365-4362.1995.tb00613.x
  7. Bogdan C, 2000, CURR OPIN IMMUNOL, V12, P64, DOI 10.1016/S0952-7915(99)00052-7
  8. BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999
  9. Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797
  10. Casgrain PA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005658
  11. Christian AE, 1997, J LIPID RES, V38, P2264
  12. Comert M, 2004, J GASTROEN HEPATOL, V19, P1052, DOI 10.1111/j.1440-1746.2004.03400.x
  13. Coppens I, 2000, J CELL BIOL, V149, P167, DOI 10.1083/jcb.149.1.167
  14. Cotter K, 2015, TRENDS BIOCHEM SCI, V40, P611, DOI 10.1016/j.tibs.2015.08.005
  15. De Cicco NNT, 2012, EXP PARASITOL, V130, P330, DOI 10.1016/j.exppara.2012.02.014
  16. Demaurex N, 2006, CELL BIOL, P163
  17. Di Giovanni J, 2010, NEURON, V67, P268, DOI 10.1016/j.neuron.2010.06.024
  18. Diaz NL, 2006, CLIN EXP DERMATOL, V31, P114, DOI 10.1111/j.1365-2230.2005.01991.x
  19. Dweik RA, 1998, J CLIN INVEST, V101, P660, DOI 10.1172/JCI1378
  20. Ehrenman K, 2013, CELL MICROBIOL, V15, P1182, DOI 10.1111/cmi.12107
  21. Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272
  22. Fujita K, 2012, NAT MED, V18, P589, DOI 10.1038/nm.2659
  23. Galle J, 2006, ATHEROSCLEROSIS, V185, P219, DOI 10.1016/j.atherosclerosis.2005.10.005
  24. Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022
  25. Goncalves VM, 2014, MICROBES INFECT, V16, P253, DOI 10.1016/j.micinf.2013.11.004
  26. Haidar B, 2006, J BIOL CHEM, V281, P39971, DOI 10.1074/jbc.M605095200
  27. Hamilton J, 2012, CLIN CHIM ACTA, V413, P1207, DOI 10.1016/j.cca.2012.03.019
  28. Han JH, 1999, J LIPID RES, V40, P830
  29. Heinrich M, 2000, ADV EXP MED BIOL, V477, P305
  30. Henard CA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003000
  31. Houben T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03796-5
  32. Huynh KK, 2007, MICROBIOL MOL BIOL R, V71, P452, DOI 10.1128/MMBR.00003-07
  33. Jongstra-Bilen J, 2017, J IMMUNOL, V199, P2149, DOI 10.4049/jimmunol.1601363
  34. Jung M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116972
  35. Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006
  36. Kawasaki-Nishi S, 2001, J BIOL CHEM, V276, P47411, DOI 10.1074/jbc.M108310200
  37. Kissing S, 2015, J BIOL CHEM, V290, P14166, DOI 10.1074/jbc.M114.628891
  38. Koller D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110486
  39. KOLODNY EH, 1976, CLIN CHIM ACTA, V70, P247, DOI 10.1016/0009-8981(76)90426-5
  40. LEAO SD, 1995, J CELL SCI, V108, P3219
  41. Lee SH, 2006, NAT MED, V12, P1403, DOI 10.1038/nm1514
  42. Liu FY, 2016, ONCOTARGET, V7, P83907, DOI 10.18632/oncotarget.13438
  43. Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
  44. Lizio M, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0560-6
  45. LUKACS GL, 1990, J BIOL CHEM, V265, P21099
  46. Madison BB, 2016, J LIPID RES, V57, P333, DOI 10.1194/jlr.C066712
  47. MANOLSON MF, 1994, J BIOL CHEM, V269, P14064
  48. Marshansky V, 2008, CURR OPIN CELL BIOL, V20, P415, DOI 10.1016/j.ceb.2008.03.015
  49. Martinez Fernando O, 2014, F1000Prime Rep, V6, P13, DOI 10.12703/P6-13
  50. Matheoud D, 2013, CELL HOST MICROBE, V14, P15, DOI 10.1016/j.chom.2013.06.003
  51. Maxson ME, 2014, J CELL SCI, V127, P4987, DOI 10.1242/jcs.158550
  52. Mindell JA, 2012, ANNU REV PHYSIOL, V74, P69, DOI 10.1146/annurev-physiol-012110-142317
  53. Miyamoto Takeshi, 2013, JAKSTAT, V2, pe24777, DOI 10.4161/jkst.24777
  54. Moore KJ, 2013, NAT REV IMMUNOL, V13, P709, DOI 10.1038/nri3520
  55. Mukbel RM, 2007, AM J TROP MED HYG, V76, P669, DOI 10.4269/ajtmh.2007.76.669
  56. Munder M, 2009, BRIT J PHARMACOL, V158, P638, DOI 10.1111/j.1476-5381.2009.00291.x
  57. Murase M, 2018, J IMMUNOL, V200, P2798, DOI 10.4049/jimmunol.1701390
  58. Okuda K, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005669
  59. Osorio y Fortea Jose, 2009, BMC Genomics, V10, P119, DOI 10.1186/1471-2164-10-119
  60. Pennings M, 2006, FEBS LETT, V580, P5588, DOI 10.1016/j.febslet.2006.08.022
  61. Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45
  62. Poea-Guyon S, 2013, J CELL BIOL, V203, P283, DOI 10.1083/jcb.201303104
  63. Pryor PR, 2004, EMBO REP, V5, P590, DOI 10.1038/sj.embor.7400150
  64. Puri V, 1999, NAT CELL BIOL, V1, P386
  65. Qi H, 2004, INFECT IMMUN, V72, P988, DOI 10.1128/IAI.72.2.988-995.2004
  66. RABINOVITCH M, 1982, J EXP MED, V155, P415, DOI 10.1084/jem.155.2.415
  67. RAGHAVAN SS, 1980, AM J HUM GENET, V32, P158
  68. Real F, 2014, CELL MICROBIOL, V16, P1549, DOI 10.1111/cmi.12311
  69. Real F, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001518
  70. Real F, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000905
  71. Roberts CW, 2003, MOL BIOCHEM PARASIT, V126, P129, DOI 10.1016/S0166-6851(02)00280-3
  72. Roth KS, 2017, PEDIAT ENDOCRINOLOGY
  73. Russell DG, 2009, NAT IMMUNOL, V10, P943, DOI 10.1038/ni.1781
  74. Sacks D, 2002, NAT REV IMMUNOL, V2, P845, DOI 10.1038/nri933
  75. Sacks D, 2002, NAT IMMUNOL, V3, P1041, DOI 10.1038/ni1102-1041
  76. SCOTT P, 1986, J IMMUNOL, V136, P1461
  77. Semini G, 2017, MICROBIOLOGYOPEN, V6, DOI 10.1002/mbo3.469
  78. Smith AN, 2005, J AM SOC NEPHROL, V16, P1245, DOI 10.1681/ASN.2004090761
  79. Soldati T, 2012, TRAFFIC, V13, P1042, DOI 10.1111/j.1600-0854.2012.01358.x
  80. Soong L, 2012, SEMIN IMMUNOPATHOL, V34, P735, DOI 10.1007/s00281-012-0350-8
  81. Soong L, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00058
  82. Steinberg D, 1997, J BIOL CHEM, V272, P20963, DOI 10.1074/jbc.272.34.20963
  83. Steinbrecher UP, 1999, BBA-MOL CELL BIOL L, V1436, P279, DOI 10.1016/S0005-2760(98)00127-1
  84. Stoka V, 2016, AGEING RES REV, V32, P22, DOI 10.1016/j.arr.2016.04.010
  85. STRAUS AH, 1993, J BIOL CHEM, V268, P13723
  86. STURGILLKOSZYCKI S, 1994, SCIENCE, V263, P678, DOI 10.1126/science.8303277
  87. Tekin NS, 2007, MEDIAT INFLAMM, DOI 10.1155/2007/78454
  88. Toledo DAM, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00174
  89. Tsukano H, 1999, MICROB PATHOGENESIS, V27, P253, DOI 10.1006/mpat.1999.0303
  90. Vieira OV, 2002, BIOCHEM J, V366, P689, DOI 10.1042/BJ20020691
  91. Wang YG, 2015, J GERIATR CARDIOL, V12, P410, DOI 10.11909/j.issn.1671-5411.2015.04.013
  92. Watterson S, 2013, BIOCHIMIE, V95, P613, DOI 10.1016/j.biochi.2012.05.024
  93. Wilson J, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000179
  94. Wong D, 2011, P NATL ACAD SCI USA, V108, P19371, DOI 10.1073/pnas.1109201108
  95. Wu HP, 2009, J BONE MINER RES, V24, P871, DOI [10.1359/JBMR.081239, 10.1359/jbmr.081239]
  96. Xia Y, 2019, AUTOPHAGY, P1, DOI [10.1080/15548627.2019.1569916, DOI 10.1080/15548627.2019.156991630681394]
  97. Xu L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000822
  98. Ylitalo R, 1999, LIFE SCI, V64, P1955, DOI 10.1016/S0024-3205(99)00140-X
  99. 2010, WHO TECH REP SER, V949, P1

Coleções
Artigos e Materiais de Revistas Científicas - FM/MPR
Artigos e Materiais de Revistas Científicas - LIM/38